@YDecurious
Account based inNigeria!
About this account
- Account based in
- Nigeria
- Connected via
- Nigeria Android App
X says this location may be affected by a proxy or VPN.
Account-level information from X, not a live location or the device used for a specific post.
Pinned Tweet
Calling all AI devs and researchers! 🤖🔬: Bio-protocol is on the hunt for talented individuals like you to join the community!. 📢
How to join:Just Shoot @AakaashMeduri, @alxdobrin
a DM)
Mention my handle @YDecurious as your referee when you sign up.
See on the side that wins
🧬DeCurious.bio/acc retweeted
Pharma spends way too much energy in court and not enough in the lab. @anagenxyz is changing that.
⚠️ Alarming: Veradermics ($MANE) has sent a Cease & Desist to another one of our pharmacy partners.
They’ve now contacted several of our pharmacies and our doctor network.
Why doesn’t a big pharma want you to have access to MINX?
Their lead drug candidate, VDPHL01, is an extended release minoxidil tablet.
The company, Veradermics Incorporated, seems to view MINX as a competing product.
Find the full video on our YouTube channel to learn more about what makes MINX different.
MINX will continue shipping.
🧬DeCurious.bio/acc retweeted
Yesterday I had the opportunity to visit our friends @anagenxyz .
Was a pleasure talking everything hair with @AJTraxler
By far the DeSci project furthest down the line of product market fit
And met also their cracked head of growth who is applying lean start up methods to their distribution!
Well done team!
🧬DeCurious.bio/acc retweeted
Lots of capital funneling into biology!
🧵 Biohub, @ENERGY, @NIH, and new funding partners today announced a major expansion of an international effort to generate and make accessible the data enabling predictive AI models of biology. Together, the organizations are investing $1.8 billion in funding, data, computation and new measurement technology - largest coordinated commitment to map the biology of the cell to power development of digital models of biology. bit.ly/3UhjoxD
🧬DeCurious.bio/acc retweeted
don't die !
🧬DeCurious.bio/acc retweeted
Bio has shared their wallet-level allocation data for the launch, enabling us to begin an audit of how their system functioned during the $NDT launch:
So far, we've found several dozen wallets that pledged zero BioXP, yet appear to have somehow received larger allocations than wallets that pledged tens of thousands of BioXP, in some cases — even when the higher-BioXP wallets had committed enough USDC to receive the larger allocation.
More info soon, as part of a general report.
We aren't making accusations against any Bio or any specific party as to how or why this appears to have happened, the BioXP system is obviously not ours and we're glad that Bio was gracious enough to share the data with us, and we're simply reporting some of what we've found so far, since yesterday we said we'd provide an update on this. And no, we do not know who any of these wallets belonged to.
Also, a quick thank you to the many of you that have sent in screenshots of the BioXP that you committed vs. the allocation that you actually received, this was extremely helpful in getting the audit started before Bio shared the complete data set.
🧬DeCurious.bio/acc retweeted
Anagen (HairDAO) just shared their latest lab roadmap.
→ Next up: testing cell-entry peptides for TWIST1, with mouse studies planned to follow.
Check out the full roadmap below:
Lab Roadmap, 10/04/2026:
TWIST1: Lead sequences selected. Publication in progress on cell culture work. Testing several cell penetration peptides this week. Mice trials start the week after.
DIAZOXIDE: Final formulation selected. Pharmacy sourcing final ingredient. First bottle in hand end of this week or early next, with blood LCMS results to immediately follow to quantify systemic absorption.
NEW PRODUCTS: Surprise. Surprise. An AR blocker, growth agonist, and novel peptide formulation all in development. More details to be revealed soon.
OLANZAPINE, FARNESOL, NALTREXONE, DOXYCYCLINE: Imaging complete. RNA-seq analysis complete. Finalizing analysis of over 5000 images via tweaks to FOWLER. Publication to follow.
FOWLER: Our proprietary hair follicle labeling model severely outperforms Fable, Astra, and Grok. FOWLER is built on 6 TB of data, from over 5000 images to date.
RSPO: Imaging in progress. Over 2100 sections. To be completed in November.
TO BE ANNOUNCED: Next batch of gene therapies, small molecules, and formulations. Stay tuned.
Buy $LAB of @anagenxyz 💎
You can see that team keeps shipping.
See you at Billionsssssssss in market capitalization 🚀🌱🔒
Lab Roadmap, 10/04/2026:
TWIST1: Lead sequences selected. Publication in progress on cell culture work. Testing several cell penetration peptides this week. Mice trials start the week after.
DIAZOXIDE: Final formulation selected. Pharmacy sourcing final ingredient. First bottle in hand end of this week or early next, with blood LCMS results to immediately follow to quantify systemic absorption.
NEW PRODUCTS: Surprise. Surprise. An AR blocker, growth agonist, and novel peptide formulation all in development. More details to be revealed soon.
OLANZAPINE, FARNESOL, NALTREXONE, DOXYCYCLINE: Imaging complete. RNA-seq analysis complete. Finalizing analysis of over 5000 images via tweaks to FOWLER. Publication to follow.
FOWLER: Our proprietary hair follicle labeling model severely outperforms Fable, Astra, and Grok. FOWLER is built on 6 TB of data, from over 5000 images to date.
RSPO: Imaging in progress. Over 2100 sections. To be completed in November.
TO BE ANNOUNCED: Next batch of gene therapies, small molecules, and formulations. Stay tuned.
🧬DeCurious.bio/acc retweeted
I imagine this will surprise a lot of people given the facial swelling, puffiness and eye bags that often accompany minoxidil.
The fact that patients report these side effects going away on MINX & that minoxidil itself shows anti-aging effects in very exciting!
🧬DeCurious.bio/acc retweeted
September in the Biosphere 🌐
- Open Science Index: We launched a searchable directory with 6,720 scientific resources.
- Launchpad: We added credit-card wallet funding through Privy.
- New Bio website: We revamped our website, bringing BIOS, OpenLabs, Buildspace, Launchpad and Biofy together in one place.
- PeptAI: Selected for Track 2 of the Adaptyv Bio × Anthropic Protein Design Competition.
- NeuroLab Ignition Sale: The sale closed 2.2× oversubscribed, with more than 442K USDC committed by over 650 participants. NDT reward claims for veBIO stakers are now live on app.bio.xyz. We also refunded all BioXP spent on the Ignition Sale.
Read the full monthly report ↓
🧬DeCurious.bio/acc retweeted
@anagenxyz optimizes today's current FDA-approved options. i.e. topical Diazoxide, MINX, Precision Dutasteride IP should all be very valuable
but for those who know - TWIST1 is the most likely cure in the world, and we've patented the sh*t out of it
Lab Roadmap, 10/04/2026:
TWIST1: Lead sequences selected. Publication in progress on cell culture work. Testing several cell penetration peptides this week. Mice trials start the week after.
DIAZOXIDE: Final formulation selected. Pharmacy sourcing final ingredient. First bottle in hand end of this week or early next, with blood LCMS results to immediately follow to quantify systemic absorption.
NEW PRODUCTS: Surprise. Surprise. An AR blocker, growth agonist, and novel peptide formulation all in development. More details to be revealed soon.
OLANZAPINE, FARNESOL, NALTREXONE, DOXYCYCLINE: Imaging complete. RNA-seq analysis complete. Finalizing analysis of over 5000 images via tweaks to FOWLER. Publication to follow.
FOWLER: Our proprietary hair follicle labeling model severely outperforms Fable, Astra, and Grok. FOWLER is built on 6 TB of data, from over 5000 images to date.
RSPO: Imaging in progress. Over 2100 sections. To be completed in November.
TO BE ANNOUNCED: Next batch of gene therapies, small molecules, and formulations. Stay tuned.
🧬DeCurious.bio/acc retweeted
Most viral drug of 2026!
🧬DeCurious.bio/acc retweeted
Dutasteride is the strongest hair loss drug there is. It's also the one men are most scared to take.
Taken as a pill it goes everywhere in your body and knocks blood DHT down about 90%. That's where the side effects come from: ED, low libido, depression, infertility.
For 20+ years the deal has been: regrow your hair, risk the rest.
Nobody seriously tried to fix that. The drug only needs to be in the follicle, not in your blood. So we spent three years figuring out how to keep it there.
Precision Dutasteride: Deliver the dose goes straight into the follicle, and blood levels come out 100x lower than the pill.
You shouldn't have to suffer to regrow your hair. Here's how we did it
🧬DeCurious.bio/acc retweeted
BioXP Refund Update
All BioXP spent in the NeuroLab Ignition Sale has been refunded to every participant including those who purchased instant BioXP.
Refunds are automatic. No action is needed. Check your transaction history on the BioXP page: app.bio.xyz/bioxp
A full list of BioXP pledges and their resulting allocations will be available on the sale page shortly.
We're working closely with the NeuroLab team to support the project's long-term research and commercial development. Stay tuned for further updates.
🧬DeCurious.bio/acc retweeted
FAMILY, CHECK YOUR PORTFOLIOS 👀
Your welcome bonus is waiting. Check your balance and see when it unlocks.
A little something from us to get you started.
revenue.family/#portfolio
